Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivar Hompland

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Acta Oncologica (Stockholm, Sweden)|May 7, 2024
Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II studyIvar Hompland, Kjetil Boye, Anne Marit Wiedswang, et al.
Annals of Surgical Oncology|February 14, 2018
Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based StudyToto Hølmebakk, Ivar Hompland, Bodil Bjerkehagen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 24, 2020
Cardiac sarcomaCarl Fredrik Bonnevie Hamre, Eirik Magnus Hobbel Kvammen, Leif Erik Vinge, et al.
Acta Oncologica (Stockholm, Sweden)|May 31, 2017
Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohortIvar Hompland, Øyvind Sverre Bruland, Toto Hølmebakk, et al.
Acta Oncologica (Stockholm, Sweden)|April 22, 2024
Survival prediction in patients with gynecological cancer irradiated for brain metastasesSilje Skjelsvik Os, Kjersti Skipar, Eva Skovlund, et al.
Annals of Surgical Oncology|March 2, 2021
Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the StomachToto Hølmebakk, Anne Marit Wiedswang, Leonardo A Meza-Zepeda, et al.
Acta Oncologica (Stockholm, Sweden)|June 14, 2022
Real-world evidence on perioperative chemotherapy in localized soft tissue sarcoma of the extremities and trunk wall; a population-based studyKjetil Boye, Ingvild Lobmaier, Marthe Rosvoll Kobbeltvedt, et al.
JCO Precision Oncology|February 1, 2023
Genomic Complexity as a Biomarker to De-Escalate Adjuvant Imatinib Treatment in High-Risk Gastrointestinal Stromal TumorKjetil Boye, Ludmila Gorunova, Bastian Gunawan, et al.
Oncotarget|March 14, 2022
Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneityLudmila Gorunova, Kjetil Boye, Ioannis Panagopoulos, et al.
Frontiers in Oncology|October 10, 2022
Inoperable or incompletely resected craniofacial osteosarcoma treated by particle radiotherapyKatharina Seidensaal, Matthias Dostal, Jakob Liermann, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Acta Oncologica (Stockholm, Sweden)|May 7, 2024
Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II studyIvar Hompland, Kjetil Boye, Anne Marit Wiedswang, et al.
Annals of Surgical Oncology|February 14, 2018
Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based StudyToto Hølmebakk, Ivar Hompland, Bodil Bjerkehagen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 24, 2020
Cardiac sarcomaCarl Fredrik Bonnevie Hamre, Eirik Magnus Hobbel Kvammen, Leif Erik Vinge, et al.
Acta Oncologica (Stockholm, Sweden)|May 31, 2017
Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohortIvar Hompland, Øyvind Sverre Bruland, Toto Hølmebakk, et al.
Acta Oncologica (Stockholm, Sweden)|April 22, 2024
Survival prediction in patients with gynecological cancer irradiated for brain metastasesSilje Skjelsvik Os, Kjersti Skipar, Eva Skovlund, et al.
Annals of Surgical Oncology|March 2, 2021
Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the StomachToto Hølmebakk, Anne Marit Wiedswang, Leonardo A Meza-Zepeda, et al.
Acta Oncologica (Stockholm, Sweden)|June 14, 2022
Real-world evidence on perioperative chemotherapy in localized soft tissue sarcoma of the extremities and trunk wall; a population-based studyKjetil Boye, Ingvild Lobmaier, Marthe Rosvoll Kobbeltvedt, et al.
JCO Precision Oncology|February 1, 2023
Genomic Complexity as a Biomarker to De-Escalate Adjuvant Imatinib Treatment in High-Risk Gastrointestinal Stromal TumorKjetil Boye, Ludmila Gorunova, Bastian Gunawan, et al.
Oncotarget|March 14, 2022
Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneityLudmila Gorunova, Kjetil Boye, Ioannis Panagopoulos, et al.
Frontiers in Oncology|October 10, 2022
Inoperable or incompletely resected craniofacial osteosarcoma treated by particle radiotherapyKatharina Seidensaal, Matthias Dostal, Jakob Liermann, et al.
Pageof 3